Daily administration of electroconvulsive shock (ECS) to rats for 10 days increased the content of [Mete]enkephalin in the hypothalamus and the striatum by 64% and 45%, respectively. The effect of ECS on the relative abundance of mRNA coding for the enkephalin precursor preproenkephalin was investigated. Analysis by cell-free translation of polyadenylylated RNA and immunoprecipitation of preproenkephalin revealed ECS-elicited increases of 79% and 14% in preproenkephalin mRNA activity in the hypothalamus and striatum, respectively. ECS treatment did not affect the general translational activity of total polyadenylylated RNA from these brain regions. A 2P-labeled probe prepared from a rat preproenkephalin cDNA clone hybridized with an apparently single species of polyadenylylated RNA of -'1450 nucleotides from both hypothalamus and striatum. Dot-blot hybridization of polyadenylylated RNA with the rat probe indicated that ECS elicits a 76% increase in the preproenkephalin mRNA abundance in the hypothalamus and no significant change in the striatum. These results suggest that ECS treatment leads to enhanced biosynthesis of the enkephalin precursor in hypothalamic neurons.
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Opioid peptides of the proenkephalin system are widely distributed throughout the nervous system and are believed to play important roles in modulating a variety of neuronal functions. These peptides, which include [Met5]enkephalin (Tyr-Gly-Gly-Phe-Met), [Leu5] enkephalin (Tyr-Gly-GlyPhe-Leu), [Met] enkephalin-Arg6-Phe7, [Met] enkephalinArg6-Gly7-Leu8, and [Met] enkephalin-Arg6-Arg7-Val'-NH2, are generated by processing the primary gene product preproenkephalin (preproenkephalin A) (1) (2) (3) (4) . Little is known about the factors that regulate enkephalin biosynthesis in enkephalinergic neurons.
Hong et al. (5) reported that daily treatment of rats with electroconvulsive shock (ECS) for 6-10 days elicits a delayed and sustained increase in the levels of [Met] enkephalin in specific brain regions, most markedly in the hypothalamus (100% increase), with smaller increases (40-60%) in the striatum, nucleus accumbens, septum, and amygdala. In contrast, ECS does not affect the hypothalamic content of ,-endorphin, an opioid peptide derived from the precursor procorticotropin-,B-endorphin. The temporal characteristics of the [Met] enkephalin increase resembled those of the antidepressive action of electroconvulsive therapy in man. It has not been determined whether the increased enkephalin content is due to an enhancement of proenkephalin biosynthesis or to an inhibition of enkephalin secretion, transport, or degradation.
A change in the cellular concentration of preproenkephalin mRNA may indicate a corresponding change in the rate of biosynthesis of proenkephalin and derived peptides. Detection of preproenkephalin mRNA is now possible either by cell-free translation of poly(A)+ RNA followed by immunoprecipitation of synthesized preproenkephalin (6, 7) or by blot hybridization of poly(A)+ RNA with a preproenkephalin cDNA probe (8) . In the present study, we have employed both methods to quantitate changes in the abundance of preproenkephalin mRNA in the hypothalamus and striatum after 10 daily administrations of ECS.
MATERIALS AND METHODS
ECS Treatment. Male Fischer 344 rats (Charles River Breeding Laboratories) weighing 200-250 g were housed four per cage with a 12-hr light-dark cycle at 21 ± 20C and 50 ± 10% relative humidity. Treatment was performed on two independent sets of rats; each set was divided into ECStreated and untreated groups. The first and second sets contained 24 and 50 rats per group, respectively. ECS was administered with an Edison electroshock apparatus through ear-clip electrodes as described (5) . Rats were shocked once per day for 10 days with 150 V at 60 Hz for 1 s, then sacrificed 24 hr after the last treatment. The hypothalami and striata were dissected according to the method of Glowinski and Iversen (9) . Tissues were frozen in liquid N2 and stored at -180°C until processed.
Preparation of Poly(A)+ RNA. Total cellular RNA was extracted by 4 M guanidinium thiocyanate and purified by repeated ethanol precipitations as described (10) with slight modifications (6) . Frozen tissues (1.2-2.0 g) of ECS-treated and control rats were processed simultaneously. The average yields of total RNA (mg/g of tissue) were as follows:
hypothalamus, control 0.97 ± 0.07, ECS 0.92 ± 0.11; striatum, control 0.63 ± 0.18, ECS 0.62 ± 0.05. Poly(A)+ RNA was purified by two cycles of affinity chromatography on oligo(dT)-cellulose (Bethesda Research Laboratories or type 7 from P-L Biochemicals). The [Met] enkephalin-Arg6-Phe7, the carboxyl terminus of preproenkephalin, as described previously (6) except that a more specific antiserum (MEAP-I) was used in Abbreviation: ECS, electroconvulsive shock.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. this study. In radioimmunoassays this antiserum at 1:5000 dilution was found to have a high affinity for [Met] Preproenkephalin cDNA Probes. The rat preproenkephalin cDNA clone designated pRPE2 was isolated from a cDNA library derived from poly(A)+ RNA from striata of Fischer 344 rats. The double-stranded oligo(dC)-tailed cDNA was prepared by the method of Land et al. (12) and annealed with oligo(dG)-tailed Pst I-cut plasmid pBR322. Annealed DNA was used to transform Escherichia coli C600 cells to tetracycline resistance. The pRPE2 clone contains a 1281-base-pair insert that corresponds to the entire coding and 3' untranslated regions as well as most of the 5' untranslated region of rat preproenkephalin mRNA. We have reported the derivation and nucleotide sequence of the pRPE2 plasmid (13) . A 513-base-pair Pst I fragment of pRPE2 DNA was isolated by agarose gel electrophoresis and purified on a NACS Prepac column (Bethesda Research Laboratories). This fragment contains sequences coding for the carboxyl-terminal 61 amino acids of preproenkephalin and corresponding to the 3'-untranslated region of the mRNA. It was labeled by nicktranslation (specific radioactivities in figure legends) with [a-32P]dCTP (2800 Ci/mmol, New England Nuclear) and used for hybridization.
The human pheochromocytoma preproenkephalin recombinant cDNA clone pHPE9 (3, 14) was kindly provided by E. Herbert and M. Comb (Univ. of Oregon, Eugene). A 918-base-pair HincII fragment of pHPE9 was labeled with [a-32P]dCTP by nick-translation and used as a hybridization probe.
RNA Blot Preparation. Poly(A)+ RNA was denatured in 50% formamide/6% formaldehyde at 55°C for 15 min and electrophoresed in a 1.3% agarose gel containing 6% formaldehyde (15) . After the gel was soaked in 10 mM sodium phosphate buffer (pH 7), the RNA was transferred to a nylon-based membrane (GeneScreen, New England Nuclear) by the capillary-blot procedure with 10x NaCl/Cit (lx NaCl/Cit = 0.15 M NaCl/0.015 M sodium citrate, pH 7) according to the manufacturer's recommendations. The membrane was washed with 1Ox NaCl/Cit for 30 min, air-dried, and baked at 80°C for 2 hr.
RNA Dot Blot Preparation. Poly(A)+ RNA was denatured at 60°C for 15 min in 7.4% formaldehyde/6x NaCl/Cit (16), then diluted in 10x NaCl/Cit and filtered by gravity flow over a 2-hr period through a GeneScreen membrane within a filtration manifold (Bethesda Research Laboratories). The membrane was washed with 2 x NaCl/Cit at 22°C for 30 min, air-dried, and baked at 80°C for 2 hr.
Blot Hybridization. Each membrane blot was prehybridized for 15-24 hr at 42°C with 10 ml of 50% formamide/0.2% polyvinylpyrrolidone/0.2% bovine serum albumin/0.2% Ficoll-400/0.05 M Tris Cl, pH 7.5/1.0 M NaCl/3.75 mM sodium pyrophosphate/1% N-lauroylsarcosine/10% dextran sulfate/denatured herring sperm DNA (100 4g/ml). The radioactive probe, in 2 ml of the same buffer without NaCl and dextran sulfate, was added (final probe concentration 10 ng/ml), and the membrane was incubated for 15-21 hr at 420C. Following hybridization, the membrane was washed twice with 100 ml of 2x NaCl/Cit/0.1% N-lauroylsarcosine and twice with 100 ml of O.x NaClICit/0.1% N-lauroylsarcosine for 10 min each time at 20'C, air-dried, and autoradiographed with Kodak XAR-5 film at 20'C in the presence of a Dupont Lightning-Plus intensifying screen.
Determination of Met-Enkephalin Content. [Metlenkephalin-like immunoreactivity was measured by radioimmunoassay as described (17) .
RESULTS
The effect of 10 daily ECS treatments on the [Metlenkephalin content of several brain regions was examined with rats of the same strain and age as those used for mRNA analyses. As shown in Table 1 , ECS significantly elevated the [Metlenkephalin content in the hypothalamus and striatum-by 64% and 45%, respectively-whereas no statistically significant increase in the hippocampus was noted. These results are consistent with those reported previously for older rats of a different strain (5) .
Changes in the functional preproenkephalin mRNA activities in the striatum and the hypothalamus as a result of ECS treatment were determined by cell-free translation ofpoly(A)+ RNA. The tissue content of total RNA was not significantly affected by ECS treatment (data in Materials and Methods). [Met]enkephalin-Arg6-Phe7. Numbers at left are as described in the legend of Fig. 2A. (B (13) . The Mr 30,000 and 22,000 bands were dense enough for reliable quantitation by scanning densitometry. As shown in Fig. 2B , the average densities of the Mr 30,000 and 22,000 bands from poly(A)+ RNA of ECS-treated rats were 71 ± 6% and 122 ± 21% higher, respectively, than those obtained from poly(A)+ RNA of control rats. The sum of synthesized Mr 30,000 and 22,000 proteins was increased 79 ± 8% by ECS treatment. The effect of ECS treatment of rats on the preproenkephalin mRNA activity of the striatum is shown in Fig. 3 . In comparison with hypothalamic poly(A)+ RNA, the observed effects of ECS were much less: an 11 + 4% increase for the Mr 30,000 protein, a 33 ± 4% increase for the Mr 22,000 protein, and a 14 ± 3% increase for the sum of the two.
The effect of ECS on preproenkephalin mRNA abundance was determined by blot-hybridization methods. Electrophoretic analysis of poly(A)+ RNA from the striatum and hypothalamus of control and ECS-treated rats is shown in Fig. 4 . For each mRNA sample, the rat and human preproenkephalin cDNA probes hybridized with an apparently single mRNA species of ==1450 bases, in accord with previous measurements of brain preproenkephalin mRNA (8, 18) . A faint band at 6000 bases, possibly an mRNA precursor, was also detected with the rat probe in overexposed autoradiograms. Effect of ECS on preproenkephalin mRNA abundance, determined by blot-hybridization analysis. Poly(A)+ RNA (4 ,ug) from striatum and hypothalamus of control (C) and ECS-treated (E) rats were electrophoresed as described in Materials and Methods. Yields of poly(A)+ RNA (,g/g of tissue) used in this experiment were as follows: striatum, control 31.3, ECS 27.2; hypothalamus, control 57.9, ECS 65.6. Translational activities of these preparations were similar to those shown in Fig. 1 . The hybridization was carried out at 42°C in the presence of nick-translated pRPE2 Pst I fragment (rat probe, 2.6 x 108 cpm/,ug) or at 30°C in the presence of nicktranslated pHPE9 HincII fragment (human probe, 1.9 x 108 cpm/,Lg). Autoradiogram exposure times with the rat and human probes were 15 hr and 3 days, respectively. Numbers at left indicate the chain length (bases) of E. coli and calf liver rRNA markers. Chain length of hybridized mRNA is also shown (arrow). Densities ECS treatment resulted in a significant increase in preproenkephalin mRNA in hypothalamic poly(A)+ RNA but not in striatal poly(A)+ RNA.
Because the preproenkephalin cDNA probes hybridize primarily with one species of poly(A)+ RNA, dot-blot hybridization was adopted for quantitation of the relative abundances of preproenkephalin mRNA. Fig. 5 probably indicates increased storage of enkephalins in the terminals of many of the neurons in which proenkephalin biosynthesis is accelerated. In contrast, ECS elicits no significant effect on the preproenkephalin mRNA abundance in the striatum, although a 45% increase in the striatal [Met]enkephalin content is found (Table 1) . Most enkephalinergic neurons in the striatum possess both cell bodies and terminals within this overall region (19, 20) . The results indicate that ECS causes these neurons to accumulate additional enkephalin in the absence of increased precursor biosynthesis, possibly by reduced enkephalin release or degradation or by increased precursor processing.
We hypothesize that ECS may increase the release of the proenkephalin family of peptides from hypothalamic neurons either directly by depolarization or indirectly through activation of other neuronal circuits; this increased release may trigger an activation of preproenkephalin gene transcription or a suppression of preproenkephalin mRNA degradation. Whether ECS affects enkephalin release or turnover has not been determined. However, there is indirect evidence for the release of opioid peptides from central neurons after a single ECS treatment; for example, naloxone, an opiate-receptor antagonist, partially blocks several ECSelicited actions, including post-ictal analgesia (23, 24) , retrograde amnesia (25) , and electroencephalographic changes (26) . In a possibly related paradigm studied by us and others, treatment of rats with haloperidol, a dopamine-receptor antagonist that increases striatal [Met] enkephalin content, release, and turnover, was shown to increase the striatal preproenkephalin mRNA abundance (7, 8) .
Of considerable interest is the possible involvement of increased enkephalin content in the antidepressant effect of electroconvulsive therapy, discussed by Hong et al. (5) . Since the septum, nucleus accumbens, and amygdala, which are believed to be functionally associated with control of mood and emotion, respond to repeated ECS with modestly increased enkephalin content (5), it is tempting to speculate that an enhancement of enkephalin biosynthesis in these areas may contribute to the antidepressive action of ECS. Quantitation of preproenkephalin mRNA abundance in these relatively small brain regions was not attempted in the present study because of the very small amounts of poly(A)+ RNA which would be obtained.
Repetitive ECS treatment is known to produce a variety of delayed and persistent perturbations in central neurotransmitter systems, including increased norepinephrine content and turnover (27) , decreased postsynaptic p-adrenergic receptor density (28) , increased tyrosine hydroxylase protein and activity (29, 30) , increased serotonin content (27) , and increased content of dynorphin [1] [2] [3] [4] [5] [6] [7] [8] immunoreactivityt in specific brain regions. We expect that the elevated hypothalamic preproenkephalin mRNA abundance described here is only one of several ECS-produced alterations in specific mRNA levels. In a broader context, the ability to detect changes in the concentrations of a specific neuronal mRNA species in discrete brain regions suggests strategies for the future study of regulatory processes operating in the central nervous system. We thank Dr. Akio Sugino for helpful advice and Dr. Marshall Nirenberg for a critical review of the manuscript.
